Cargando…

Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects

INTRODUCTION: Ultra rapid lispro (URLi) is a novel insulin lispro formulation that was developed to more closely match physiological insulin secretion. The aims of this study were to demonstrate the bioequivalence (BE) of a concentrated formulation (U200) of URLi to the U100 formulation of URLi afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linnebjerg, Helle, LaBell, Elizabeth Smith, Dellva, Mary Anne, Coutant, David E., Leohr, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376802/ https://www.ncbi.nlm.nih.gov/pubmed/32535742 http://dx.doi.org/10.1007/s13300-020-00848-4

Ejemplares similares

Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog(®) Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data
por: Leohr, Jennifer, et al.
Publicado: (2021)

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial
por: Linnebjerg, Helle, et al.
Publicado: (2020)

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study
por: Leohr, Jennifer, et al.
Publicado: (2020)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study
por: Heise, Tim, et al.
Publicado: (2020)

Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double‐blind meal test early‐phase study
por: Kazda, Christof, et al.
Publicado: (2021)

Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension
por: Bue-Valleskey, Juliana, et al.
Publicado: (2021)

Ultra rapid lispro (URLi) shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early‐phase study
por: Leohr, Jennifer, et al.
Publicado: (2021)

Efficacy and safety of ultra‐rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO‐Peds trial
por: Wadwa, R. Paul, et al.
Publicado: (2022)

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes
por: Bergenstal, Richard M., et al.
Publicado: (2023)

Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study
por: Klaff, Leslie, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
por: de la Peña, Amparo, et al.
Publicado: (2011)

Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain
por: Rubio de Santos, Miriam, et al.
Publicado: (2022)

Penny Ur's 100 teaching tips /
por: Ur, Penny
Publicado: (2016)

Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder
por: AlTaweel, Waleed, et al.
Publicado: (2011)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Pharmacokinetics and bioequivalence assessment of optimized directly compressible Aceclofenac (100 mg) tablet formulation in healthy human subjects
por: Bushra, Rabia, et al.
Publicado: (2020)

Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Krebs-Brown, Axel, et al.
Publicado: (2019)

Mesons production in $p$ + U, O + U and S + U interactions at 200 Gev/nucleon
por: Abreu, M C, et al.
Publicado: (1991)

Bioequivalence of two oral formulations of tebipenem pivoxil hydrobromide in healthy subjects
por: Gupta, Vipul K., et al.
Publicado: (2022)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan‐Approved Humalog Insulin Lispro in Healthy Japanese Subjects
por: Shiramoto, Masanari, et al.
Publicado: (2022)

$\omega$, $\varrho$ and $\phi$ production in $p$ + U, O + U and S + U collisions at 200 Gev/c
por: Abreu, M C, et al.
Publicado: (1990)

Bioequivalence of two esomeprazole magnesium enteric-coated formulations in healthy Chinese subjects
por: Liu, Zheng-Zhi, et al.
Publicado: (2020)

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
por: Shimizu, Hidetoshi, et al.
Publicado: (2021)

Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany
por: Chen, Jieling, et al.
Publicado: (2021)

Outcomes of ureteroscopy (URS) for stone disease in the paediatric population: results of over 100 URS procedures from a UK tertiary centre
por: Jones, Patrick, et al.
Publicado: (2019)

Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog(®) in Japanese patients with type 1 diabetes
por: Shiramoto, Masanari, et al.
Publicado: (2020)

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO‐Pump‐2
por: Warren, Mark, et al.
Publicado: (2021)

The production of $\phi$ in 200 GeV/nucleon S - U and O - U interactions
por: Baldisseri, Alberto
Publicado: (1990)

Case of subcutaneous insulin resistance syndrome treated with ultra‐rapid insulin lispro
por: Ishii, Takahiro, et al.
Publicado: (2021)

What is the value of faster acting prandial insulin? Focus on ultra rapid lispro
por: Heise, Tim, et al.
Publicado: (2022)

Bioequivalence assessment of two formulations of ibuprofen
por: Al-Talla, Zeyad A, et al.
Publicado: (2011)

Transverse momentum of dimuons produced in $p$ - U, O - U and S - U collisions at 200 GeV/nucleon
por: Guichard, A, et al.
Publicado: (1991)

Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects
por: Tjandrawinata, Raymond R, et al.
Publicado: (2012)

Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects
por: Ju, Gehang, et al.
Publicado: (2020)

Bioequivalence assessment of two Ticagrelor formulations under fasting condition in healthy Pakistani subjects
por: Hashmi, Naghma, et al.
Publicado: (2023)

$\pi$ and $K$ production in 200 GeV/nucleon: O - U and S - U interactions
por: Abreu, M C, et al.
Publicado: (1988)

Study of $J/\psi$ production in $p$ - U, O - U and S - U interactions at 200-GeV per nucleon
por: Baglin, C, et al.
Publicado: (1991)

$\phi$, $\varrho$, and $\omega$ production in $p$ - U, O - U and S - U reactions at 200 GeV per nucleon
por: Baglin, C, et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_clocdna2v510qulqtkph06ucqb